£81.12

It has never been this cheap. We have no record of a lower price.

£81 today · cheaper than every other day in the last 3 months

Springer New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical
Generating forecast…
£85.94 £80.64 £81.79 £82.95 £84.11 £85.27 £86.42 23 July 2026 05 August 2026 19 August 2026 01 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 36 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 55 days • 2 price levels

Days at Price
Current Price
6 days · current 49 days 0 12 25 37 49 £81 £86 Days at Price

Price Analysis

Most common price: £86 (49 days, 89.1%)

Price range: £81 - £86

Price levels: 2 different prices over 55 days

Description

Since the introduction of new anthracycline derivatives and anthrachi none analogues a few years ago, aclacinomycin A (Aclarubicin) has become an established agent for the treatment of hematologic malig nancies. A special symposium was therefore held during the congress of the German Society of Hermatology and Oncology in Hannover in October 1989 to provide an up-to-date overv.iew. Leading experts from the United States, Sweden, and Germany reported on the results being obtained with aclacinomycin A, alone or combined with other agents, in patients with acute leukemias and myelodysplastic syndromes. This book is based on their contributions. As regards single-agent treatment, aclacinomycin A in myelodys plastic syndromes is dealt with, as well as its application in older patients with acute myeloid leukemia. Four contributions are devoted to the use of aclacinomycin A in combination with conventional or intermediate dose cytosine arabinoside or etoposide in patients with relapsed or refractory acute myeloid leukemia. The results reported indicate that aclacinomycin A has substantial activity in the treatment of hematologic malignancies. In summary, this book provides a valuable update on the current status of aclacinomycin A as used by experts in the treatment of he matologic malignancies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 August 1990
Listed Since
10 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Childhood Acute Lymphoblastic Leukemia
84% match

Childhood Acute Lymphoblastic Leukemia

Springer

£92.00 06 Aug 2026
Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies
83% match

Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies

Springer

£88.07 05 Aug 2026
Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)
83% match

Myelodysplastic Syndromes: Diagnosis - Prognosis - Therapy (Hematologic Malignancies)

Springer

£73.14 17 Oct 2026
Childhood Leukemia: A Practical Handbook (Pediatric Oncology)
82% match

Childhood Leukemia: A Practical Handbook (Pediatric Oncology)

Springer

£100.25 14 Sep 2026
HIV-associated Hematological Malignancies
82% match

HIV-associated Hematological Malignancies

Springer

£103.27 07 Aug 2026
Chronic Myeloid Leukemia (Hematologic Malignancies)
82% match

Chronic Myeloid Leukemia (Hematologic Malignancies)

Springer

£109.97 06 Aug 2026
Chronic Myeloproliferative Disorders
82% match

Chronic Myeloproliferative Disorders

CRC Press

£145.99 06 Aug 2026
Text Book on Clinical Haematology-Oncology
82% match

Text Book on Clinical Haematology-Oncology

Scholars' Press

£70.03 09 Sep 2026
Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)
81% match

Leukemia: Advances in Research and Treatment: 64 (Cancer Treatment and Research, 64)

Springer

£76.42 07 Aug 2026
Biology and Therapy of Acute Leukemia: Proceedings of the Seventeenth Annual Detroit Cancer Symposium Detroit, Michigan ― April 12–13, 1984: 33 (Developments in Oncology, 33)
81% match

Biology and Therapy of Acute Leukemia: Proceedings of the Seventeenth Annual Detroit Cancer Symposium Detroit, Michigan ― April 12–13, 1984: 33 (Developments in Oncology, 33)

Springer

£113.77 07 Aug 2026
The Myelodysplastic Syndromes
81% match

The Myelodysplastic Syndromes

Springer

£112.68 04 Aug 2026
Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)
81% match

Chronic Leukemias and Lymphomas: Biology, Pathophysiology, and Clinical Management (Current Clinical Oncology)

Humana

£80.67 05 Aug 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
81% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.74 06 Aug 2026
Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer
81% match

Invasive Mykosen bei Patienten mit akuter myeloischer Leukämie: Inzidenz, Letalität und Analyse der Diagnosekriterien der European Organization for Research and Treatment of Cancer

£45.00 05 Sep 2026
Advances in Hematopoietic Stem Cell Transplantation and Molecular Therapy: 144 (Recent Results in Cancer Research, 144)
80% match

Advances in Hematopoietic Stem Cell Transplantation and Molecular Therapy: 144 (Recent Results in Cancer Research, 144)

Springer

£78.01 14 Sep 2026
Langzeitergebnisse bei akuter myeloischer Leukämie: Chemotherapie mit Cytosinarabinosid und Idarubicin
80% match

Langzeitergebnisse bei akuter myeloischer Leukämie: Chemotherapie mit Cytosinarabinosid und Idarubicin

VDM Verlag

£42.00 18 Aug 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
80% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 06 Aug 2026
Oncologic Therapies
80% match

Oncologic Therapies

Springer

£81.74 05 Aug 2026
Biologic Therapy of Leukemia (Contemporary Hematology)
80% match

Biologic Therapy of Leukemia (Contemporary Hematology)

Humana

£73.14 18 Aug 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
80% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 08 Aug 2026
Radiological Imaging in Hematological Malignancies (Medical Radiology / Diagnostic Imaging)
80% match

Radiological Imaging in Hematological Malignancies (Medical Radiology / Diagnostic Imaging)

Springer

£217.50 20 Oct 2026
Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML
80% match

Leukemia - Incorporating Acute & Chronic ALL, AML, CLL & CML

CREATESPACE

£32.58 05 Aug 2026
Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)
79% match

Myelodysplastic Syndromes & Secondary Acute Myelogenous Leukemia: Directions for the New Millennium: 108 (Cancer Treatment and Research, 108)

Springer

£113.76 14 Sep 2026
Multiple Myeloma: Diagnosis and Treatment
79% match

Multiple Myeloma: Diagnosis and Treatment

Springer

£74.21 08 Aug 2026